Recombinant human interleukin-1 receptor antagonist injection
重组人白细胞介素-1受体拮抗剂注射液
Report date: 2025/04/07 15:07:08
Base Information
Drug NameRecombinant human interleukin-1 receptor antagonist injection
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesZhejiang Hisun Pharmaceutical Co LtdEgen Biology Technology (Beijing) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A